Literature DB >> 12410804

Transforming growth factor-beta (TGF-beta) and tissue transglutaminase expression in the small intestine in children with coeliac disease.

T Hansson1, A-K Ulfgren, E Lindroos, A DannAEus, I Dahlbom, L Klareskog.   

Abstract

The production of cytokines from T cells and macrophages is of potential importance for the histological changes apparent in coeliac disease (CoD). Small intestinal biopsy specimens from children with CoD and disease control subjects were investigated for their content of cytokines and tissue transglutaminase (tTG). The transforming growth factor-beta1 (TGF-beta1) expression was increased in the lamina propria of children with villous atrophy. In contrast, TGF-beta3 was expressed at a higher level in the epithelium and the lamina propria of the disease control subjects. The tTG expression was increased in the small intestine of CoD patients as compared with that in subjects. Interleukin-4 (IL-4) was detected in the lamina propria of both CoD patients and controls, and some of the investigated biopsy specimens also showed IL-4 expression in the epithelium. We conclude that children with active CoD could have an altered expression of TGF-beta and tTG in the small intestine and that a disturbed regulation of TGF-beta may be of importance in the immune pathogenesis of CoD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410804     DOI: 10.1046/j.1365-3083.2002.01157.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  17 in total

Review 1.  New understanding of gluten sensitivity.

Authors:  Umberto Volta; Roberto De Giorgio
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-28       Impact factor: 46.802

Review 2.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 3.  New aspects in celiac disease.

Authors:  M I Torres; M A López Casado; A Ríos
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

Review 4.  Non-celiac gluten sensitivity: questions still to be answered despite increasing awareness.

Authors:  Umberto Volta; Giacomo Caio; Francesco Tovoli; Roberto De Giorgio
Journal:  Cell Mol Immunol       Date:  2013-08-10       Impact factor: 11.530

Review 5.  Effector and suppressor T cells in celiac disease.

Authors:  Giuseppe Mazzarella
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

6.  Enhanced interleukin-18 levels in the peripheral blood of children with coeliac disease.

Authors:  H Lettesjö; T Hansson; A Bergqvist; J Grönlund; A Dannaeus
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

7.  Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency.

Authors:  I R Korponay-Szabó; I Dahlbom; K Laurila; S Koskinen; N Woolley; J Partanen; J B Kovács; M Mäki; T Hansson
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

8.  Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity.

Authors:  W Dieterich; D Trapp; B Esslinger; M Leidenberger; J Piper; E Hahn; D Schuppan
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

9.  Tissue transglutaminase expression in celiac mucosa: an immunohistochemical study.

Authors:  Julia Gorgun; Anna Portyanko; Yuri Marakhouski; Eugeni Cherstvoy
Journal:  Virchows Arch       Date:  2009-09-12       Impact factor: 4.064

10.  Tryptophan metabolism and indoleamine 2,3-dioxygenase expression in coeliac disease.

Authors:  M I Torres; M A López-Casado; P Lorite; A Ríos
Journal:  Clin Exp Immunol       Date:  2007-03-15       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.